Autopsy report · NCT04090242

Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes

“Enrollment halted prematurely due to the Covid-19 pandemic”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 9 months before it stopped.
• 58 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Becton, Dickinson and Company

Sponsor type

Industry

Conditions

Diabetes Mellitus, Type 2

Interventions

BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle

Participants

58

Sites

4

Countries

United States

Trials that died the same way

• Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
  “Enrollment was affected due to the COVID-19 pandemic” (83% match in meaning)
• Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
  “Enrollment slower than anticipated and interrupted by COVID-19 pandemic” (82% match in meaning)
• An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
  “Recruitment/enrollment ended early due to the COVID-19 pandemic” (80% match in meaning)
• Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)
  “Due to the COVID-19 pandemic, study enrollment has been prematurely terminated.” (80% match in meaning)
• Effects of rTMS on Human Brain Activity
  “Never started enrollment due to COVID-19 closures” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.